Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis
Tomohiro Watanabe(Kindai University Sakai Hospital), Warren Strober(Office of Extramural Research)
Cited by 328
Related Papers
Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β
|The Journal of Experimental Medicine|2001|1.6k
Anti–Interleukin-12 Antibody for Active Crohn's Disease
|New England Journal of Medicine|2004|853
Experimental Models of Inflammatory Bowel Diseases
|Cellular and Molecular Gastroenterology and Hepatology|2015|704
Induction of IL-13 Triggers TGF-β1-Dependent Tissue Fibrosis in Chronic 2,4,6-Trinitrobenzene Sulfonic Acid Colitis
|The Journal of Immunology|2007|196
Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn’s disease
|Journal of Clinical Investigation|2018|111